During the past decade, La Rabta Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "La Rabta Hospital" #1 sponsor was "Gynuity Health Projects" with 7 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Shire" with 2 trials sponsored, "Tunis University" with 2 trials sponsored and "C.T. Development America, Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "La Rabta Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Centre Hospitalier Régional Universitaire de Nancy" with 1 trials as a collaborator, "Clinic No. 2 of Tashkent Medical Academy" with 1 trials as a collaborator, "Clinique du Parc, Tunisia" with 1 trials as a collaborator and "George Clinical Pty Ltd" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "La Rabta Hospital" are "Generalized Pustular Psoriasis" (3 trials), "Gaucher Disease, Type 1" (2 trials), "Medical Abortion" (2 trials), "Abortion, Induced" (1 trials) and "Amyloidosis" (1 trials). Many other conditions were trialed in "La Rabta Hospital" in a lesser frequency.

Most popular intervention types in "La Rabta Hospital" are "Drug" (14 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Spesolimab" (3 trials), "AS colimycin (colistin)" (1 trials), "AS colistin and "imipenem"" (1 trials) and "AS colistin and imipenem" (1 trials). Other intervention names were less common.

The vast majority of trials in "La Rabta Hospital" are 12 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "La Rabta Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in La Rabta Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in La Rabta Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".